<?xml version="1.0" encoding="UTF-8"?>
<p>Historically, systemic corticosteroids, usually oral prednisone alone or in combination with immunosuppressive drugs, have been used as the mainstay treatment in pemphigus vulgaris (
 <xref rid="B7" ref-type="bibr">7</xref>). Although these agents have led to substantial improvement in the prognosis of the disease, treatment complications, especially the risk of infections, remain major areas of concern (
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>). When used as pulse therapy, steroids may lead to cardiac side effects (
 <xref rid="B10" ref-type="bibr">10</xref>, 
 <xref rid="B11" ref-type="bibr">11</xref>). This concern becomes even more pronounced during the epidemic of some infectious agents, including the coronavirus.
</p>
